All medications in both groups were administered orally. At the time the study began the only levofloxacin available in the market was Truxa® which was used throughout the study.
Para el momento del inicio del estudio la única levofloxacina del mercado era la Truxa ® y la terapia con este antibiótico se mantuvo durante todo la investigación.